Cancer drug costs Rs 2,700, sells for Rs 27,000: SC questions 10x markup at hospitals
The Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The court also sought scrutiny of hospitals that force patients to buy drugs from in-house pharmacies, saying such practices burden patients and taxpayers.
The Economic Times ·